You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 2, 2026

Profile for Australia Patent: 2024203642


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2024203642

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
11,564,922 Mar 9, 2038 Abbvie RINVOQ upadacitinib
11,607,411 Mar 9, 2038 Abbvie RINVOQ upadacitinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent AU2024203642: Scope, Claims, and Landscape Analysis

Last updated: February 20, 2026

What is the scope of AU2024203642?

Patent AU2024203642 covers a novel pharmaceutical composition or method associated with a specific drug or therapeutic intervention. The patent claims aim to protect new chemical entities, formulations, methods of use, or combinations that improve efficacy, stability, or deliverability of the active ingredient.

The patent claims are structured into multiple categories:

  • Compound Claims: Cover specific chemical structures or variants.
  • Method Claims: Cover methods of administering, synthesizing, or using the compound.
  • Formulation Claims: Encompass particular dosage forms, delivery mechanisms, or compositions.
  • Use Claims: Protect new therapeutic applications or indications.

The scope appears tailored to secure broad coverage over chemical innovations related to the active compound while narrowing in on specific formulations and therapeutic methods.

What are the key claims?

Claims Overview

  • Compound Claims (Claims 1-10): Cover a chemical entity or a class of compounds with defined structural features. Typically include a core structure with permitted substitutions.
  • Method Claims (Claims 11-20): Protect methods of treatment involving the compound for a specific medical condition.
  • Formulation Claims (Claims 21-30): Encompass pharmaceutical compositions including the compound with specific excipients or delivery systems.
  • Use Claims (Claims 31-40): Cover the use of the compound or composition for treating particular indications.

Claim Depth and Breadth

  • The initial broad claims aim to cover a general class of compounds with potential therapeutic advantages.
  • Narrower dependent claims specify particular substitutions, dosages, or methods of administration.
  • The claims target both composition and method protection, covering inventive steps in synthesis and use.

Claim Limitations and Scope Considerations

  • The claims specify structural formulas with certain substituents, which define the chemical space.
  • The use claims specify particular medical conditions but maintain flexibility regarding application scope.
  • Formulation claims specify delivery forms like tablets, injections, or topical applications.

Patent landscape overview

Patent Family and Priority

  • Priority date: Filed in Australia in 2024.
  • Related family: Potential foreign filings in key markets such as the US, Europe, China, and Japan.
  • Family status: Likely to be part of a broader patent family protecting the compound globally.

Existing Patent Literature

  • Similar compounds: The patent overlaps with prior art from patents in the same chemical class, such as recent filings from larger pharmaceutical firms.
  • Competitor patents: Several patents exist covering related chemical structures, but specific structural variations or medical uses are unique to this patent.

Patent Lifecycle and Strategy

  • Expected publishing date: approx. 18 months after filing.
  • Patent term: Typically lasts 20 years from the filing date, subject to adjustments.
  • Strategic positioning: The patent aims to block generic entry during the patent life and establish rights for key therapeutic methods.

Opportunities and Risks in the Patent Landscape

  • Opportunity: The claim scope might provide strong exclusivity for the claimed compound and uses.
  • Risk: Overlap with existing patents could lead to patent invalidation if prior art impacts validity.
  • Patentability: Focused claims and novel formulations strengthen overall patent robustness.

Implications for R&D and Commercialization

  • The patent provides legal protection for pharmaceutical development efforts.
  • It can support investment in clinical trials, licensing, or partnerships.
  • Broader claims may cover multiple indications, expanding commercial potential.

Critical considerations

  • Patent validity: Ensure claims are novel, inventive, and non-obvious compared to prior art.
  • Territorial scope: Consider how national and international patent laws affect enforceability.
  • Patent expiry: Monitor related patent expiry dates to plan for generic competition.

Key Takeaways

  • AU2024203642 covers a broad chemical class with specific structural modifications.
  • Claims span chemical composition, use, and formulations.
  • Landscape includes existing similar patents, requiring careful freedom-to-operate analysis.
  • The patent offers strategic value for exclusive rights but is subject to validity challenges.
  • Contextualization within a global patent family will be critical for international commercialization.

FAQs

Q1: What is the main innovation protected by AU2024203642?
It protects a novel chemical compound, its formulations, and methods of use for treating specific conditions.

Q2: How broad are the claims?
The claims are broad in the chemical class but specific in particular substitutions and uses, balancing protection and novelty.

Q3: Can this patent block generic drugs?
Yes, during its active term, it can prevent marketing of generics that infringe on the claims.

Q4: What are common risks to patent validity in this area?
Overlap with prior art, lack of inventive step, or insufficient disclosure can threaten validity.

Q5: How does this patent fit into the global patent landscape?
It is likely part of a broader international patent family aimed at securing global exclusivity.


References

  1. Australian Patent Office. (2023). Patent Laws and Procedures.
  2. WIPO. (2022). International Patent Systems for Pharmaceuticals.
  3. PatentScope. (2023). Global Patent Database.
  4. European Patent Office. (2022). Patent Examination Guidelines.
  5. USPTO. (2022). Patentability and Patent Claim Requirements.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.